Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma"

Head and Neck

Volumn 37, Issue 12, 2015, Pages 1788-1793

  Jara, Sebastian M ^a   Bhatnagar, Ramneesh ^a,b   Guan, Hui ^a,c   Gocke, Christopher D ^a   Ali, Syed Z ^a   Tufano, Ralph P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRAF mutation; fine needle aspiration biopsy; molecular marker testing; papillary thyroid carcinoma; suspicious for papillary carcinoma

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; TUMOR MARKER;

ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLICULAR CARCINOMA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUTATIONAL ANALYSIS; PAPILLARY CARCINOMA; PATIENT DECISION MAKING; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROID CARCINOMA; THYROIDECTOMY; TUMOR VOLUME; ADOLESCENT; AGED; CARCINOMA; CHILD; ECONOMICS; GENETICS; MARYLAND; MICHIGAN; MUTATION; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; THYROID NEOPLASMS; THYROID NODULE;

ADOLESCENT; ADULT; AGED; BIOMARKERS, TUMOR; BIOPSY, FINE-NEEDLE; CARCINOMA; CHILD; FEMALE; HUMANS; MALE; MARYLAND; MICHIGAN; MIDDLE AGED; MUTATION; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY;

EID: 84954321397     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23829     Document Type: Article

References (42)

1. Castro MR, Gharib H,. Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls. Endocr Prac 2003; 9: 128-136.
2. Blansfield JA, Sack MJ, Kukora JS,. Recent experience with preoperative fine-needle aspiration biopsy of thyroid nodules in a community hospital. Arch Surg 2002; 137: 818-821.
3. Renshaw AA,. Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol 2001; 116: 477-482.
4. Ravetto C, Colombo L, Dottorini ME,. Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 2000; 90: 357-363.
5. Layfield LJ, Cibas ES, Gharib H, Mandel SJ,. Thyroid aspiration cytology: current status. CA Cancer J Clin 2009; 59: 99-110.
6. Baloch ZW, LiVolsi VA, Asa SL, et al., Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008; 36: 425-437.
7. Ali SZ, Cibas ES,. The Bethesda System for Reporting Thyroid Cytopathology. New York, NY: Springer; 2010.
8. Theoharis CG, Schofield KM, Hammers L, Udelsman R, Chhieng DC,. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 2009; 19: 1215-1223.
9. Cohen Y, Rosenbaum E, Clark DP, et al., Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res 2004; 10: 2761-2765.
10. Jo YS, Huang S, Kim YJ, et al., Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas. Clin Endocrinol (Oxf) 2009; 70: 139-144.
11. Marchetti I, Lessi F, Mazzanti CM, et al., A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Thyroid 2009; 19: 837-842.
12. Mekel M, Nucera C, Hodin RA, Parangi S,. Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules. Am J Surg 2010; 200: 136-143.
13. Moon HJ, Kwak JY, Kim EK, et al., The role of BRAFV600E mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology. Ann Surg Oncol 2009; 16: 3125-3131.
14. Rowe LR, Bentz BG, Bentz JS,. Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules. Cytojournal 2006; 3: 10.
15. Sapio MR, Guerra A, Posca D, et al., Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocr Relat Cancer 2007; 14: 1089-1097.
16. Sapio MR, Posca D, Raggioli A, et al., Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol (Oxf) 2007; 66: 678-683.
17. Zatelli MC, Trasforini G, Leoni S, et al., BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies. Eur J Endocrinol 2009; 161: 467-473.
18. Adeniran AJ, Theoharis C, Hui P, et al., Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study. Thyroid 2011; 21: 717-723.
19. Mathur A, Weng J, Moses W, et al., A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy. Surgery 2010; 148: 1170-1176; discussion 1176-1177.
20. Nikiforov YE, Ohori NP, Hodak SP, et al., Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011; 96: 3390-3397.
21. Moses W, Weng J, Sansano I, et al., Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg 2010; 34: 2589-2594.
22. Nikiforova MN, Nikiforov YE,. Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009; 19: 1351-1361.
23. Gilfillan CP,. Review of the genetics of thyroid tumours: diagnostic and prognostic implications. ANZ J Surg 2010; 80: 33-40.
24. Xing M,. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007; 28: 742-762.
25. Lee JH, Lee ES, Kim YS,. Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis. Cancer 2007; 110: 38-46.
26. Cohen Y, Xing M, Mambo E, et al., BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 2003; 95: 625-627.
27. Kim SW, Lee JI, Kim JW, et al., BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population. J Clin Endocrinol Metab 2010; 95: 3693-3700.
28. Chung KW, Yang SK, Lee GK, et al., Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol (Oxf) 2006; 65: 660-666.
29. Xing M, Westra WH, Tufano RP, et al., BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005; 90: 6373-6379.
30. Lupi C, Giannini R, Ugolini C, et al., Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 2007; 92: 4085-4090.
31. Xing M, Clark D, Guan H, et al., BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 2009; 27: 2977-2982.
32. Elisei R, Ugolini C, Viola D, et al., BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab 2008; 93: 3943-3949.
33. Yip L, Nikiforova MN, Carty SE, et al., Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation. Surgery 2009; 146: 1215-1223.
34. Baloch Z, LiVolsi VA,. Pathology of the thyroid gland. Philadelphia, PA: Churchill Livingston; 2002. pp 61-88.
35. Tsiatis AC, Norris-Kirby A, Rich RG, et al., Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mol Diagn 2010; 12: 425-432.
36. Proietti A, Giannini R, Ugolini C, et al., BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features. Thyroid 2010; 20: 1263-1270.
37. Min HS, Lee C, Jung KC,. Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population. J Korean Med Sci 2013; 28: 534-541.
38. Lee SR, Jung CK, Kim TE, et al., Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of ras mutation testing. Thyroid 2013; 23: 1416-1422.
39. Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P,. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology. Cytopathology 2014; 25: 146-154.
40. Williams BA, Bullock MJ, Trites JR, Taylor SM, Hart RD,. Rates of thyroid malignancy by FNA diagnostic category. J Otolaryngol Head Neck Surg 2013; 42: 61.
41. Blansfield JA, Sack MJ, Kukora JS,. Recent experience with preoperative fine-needle aspiration biopsy of thyroid nodules in a community hospital. Arch Surg 2002; 137: 818-821.
42. Wu HH, Rose C, Elsheikh TM,. The Bethesda system for reporting thyroid cytopathology: an experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy. Diagn Cytopathol 2012; 40: 399-403.